CClinicalTrials.gg
CompletedNCT05750238Updated Mar 1, 2023

Relationship Between Stress, Anxiety, Depression, Sexual Function and Marital Adjustment in Nurses

An observational study in Stress, Anxiety Disorders and Sexual Behavior, sponsored by T.C. ORDU ÜNİVERSİTESİ. Completed at 1 site in Turkey. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-01.

Sponsored by T.C. ORDU ÜNİVERSİTESİ · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
302
Ages
18 Years and older
Sex
Female
01

Study summary

One of the factors that increase harmony in marriage is sexual life and sexual satisfaction (Erdinç, 2018). Sexual intercourse is one of the pillars of a successful family; accordingly, functionality in this area greatly affects marital adjustment (Atrian, 2018). Studies show an important relationship between sexual adjustment and marital adjustment (Türkseven et al., 2020; Begdeş, 2021). Negative workplace factors such as occupational stress and long working hours affect the physical and mental states of nurses (Oyeleye et al., 2013; Chesak et al., 2019).

This study was planned to determine the relationship between stress, anxiety, depression, sexual function and marital adjustment in nurses.

02

Conditions studied

  • Stress
  • Anxiety Disorders
  • Sexual Behavior

Browse trials for

03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 302 is above the median of 150 across 606 observational studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

T.C. ORDU ÜNİVERSİTESİ is the lead sponsor of 87 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

female employees working in the nursing profession were included.

Inclusion criteria

  • Volunteer to participate in the research,
  • Over the age of 18,
  • Married,
  • Those whose spouse is alive and living with their spouse will be included.

Exclusion criteria

Exclusion Criteria:

  • Having a chronic disease (hypertension, diabetes),
  • Nurses who are pregnant,
  • Those who use drugs that may affect sexual function (beta-blockers, antihypertensives, antidepressants, antipsychotics, etc.) will be excluded from the study.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
302 participants (actual)
Target follow-up
6 Months
Patient registry
Yes

Interventions

  • Otherno intervention

    no intervention, survey was applied to the participants

06

What researchers measure

Primary outcomes

  1. Marriage Adjustment Scale Marriage Adjustment Scale

    It is a 15-item Likert-type scale developed by Locke and Wallace (1959) to evaluate marital satisfaction and marital adjustment level. It was adapted into Turkish by Tutarel and Kışlak (1999). The cut-off point of the scale is 43.5. The lowest score obtained from the scale indicates that the woman is very unhappy in her marriage, and the highest score indicates that the woman is very satisfied and happy in her marriage. The Cronbach alpha reliability coefficient in the form of the scale is 0.84 (Tutarel Kışlak, 1999).

    Time frame: 3 hours

  2. Arizona Sexual Experiences Scale

    The Arizona Sexual Experiences Scale (ACEX) was developed by McGahuey et al. (2000) to measure sexual dysfunctions. The scale was adapted to Turkish by Soykan (2004) and its validity and reliability study was conducted. The Women's Form (ACYÖ) Scale is 6-point Likert type and consists of 5 questions. This scale is a Likert-type scale designed to evaluate the five basic components of sexual function: arousal, arousal, vaginal wetting, ability to reach orgasm, and satisfaction with orgasm. Scoring is done from 1 to 6.

    Time frame: 1 hour

  3. Depression, Anxiety and Stress 21 Scale (DASS-21)

    Depression Anxiety Stress-21 Scale (DASS-21); It was developed by Lovibond and Lovibond (Lovibond and Lovibond, 1995) and adapted into Turkish by Sarıçam (Sarıçam, 2017). The scale is likert type and consists of 21 items. There are 7 items in each of the anxiety, depression and stress sub-dimensions. Scale items are scored between "0" and "3", ranging from never to always. The scale evaluates the symptoms of depression, anxiety and stress in the last week. The cut-off score was ≥10 in depression, ≥8 in anxiety, and ≥15 in the stress dimension (Lovibond \& Lovibond, 1995). Cronbach alpha internal consistency reliability coefficient of the scale; It was found to be 0.81 for the stress subscale, 0.85 for the anxiety subscale, and 0.87 for the depression subscale (Sarıçam, 2018)

    Time frame: 3 hour

07

Study locations

1 site
  • Ordu University
    Samsun, 55080, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05750238
Lead sponsor
T.C. ORDU ÜNİVERSİTESİ
Responsible party
Nülüfer Erbil (Prof. Dr., T.C. ORDU ÜNİVERSİTESİ) — Principal investigator
First posted
Mar 1, 2023
Start date
Jan 1, 2022
Primary completion
Jun 1, 2022
Completion
Dec 1, 2022
Last update
Mar 1, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion